SBI Welcomes Bio-innovators to Dublin to Launch New Facilities
Thursday, 05 December, 2013
Today, Minister for Research and Innovation, Seán Sherlock TD together with two leading innovators in health research were in Dublin to help launch a new state of the art research facility for Systems Biology Ireland and highlight the possible upcoming breakthroughs in personalised medicine. Systems Biology Ireland, supported by the Department of Jobs, Enterprise and Innovation through Science Foundation Ireland, combines the power of computers and modern biology to understand diseases such as cancer and develops diagnostics and therapies that are tailored to the individual patient. Finding the right drug for the right patient is a major problem, especially in cancer therapy where often only one third of patients respond to treatment. The goal of Systems Biology Ireland’s research is to double the number of patients that cancer drugs work for by 2020.
Speaking at the launch of the new building Minister Sherlock, said: “This magnificent new facility is a major step that will enable Systems Biology Ireland to lead in the advancement of personalised medicine on a global scale, and in a key area prioritised for investment under Horizon 2020. Establishment of a purpose-built, world class facility of this calibre, supported by the Department of Jobs, Enterprise and Innovation through Science Foundation Ireland and the Programme for Research in Third Level Institutions, is a notable achievement for Ireland.”
“To really take advantage of the new drugs becoming available for targeted therapies, we urgently need the telescopic sights that will allow us to take each patient’s cancer into the crosshairs individually. Systems Biology Ireland is developing these sights” says Walter Kolch, Director of Systems Biology Ireland.
Áine Lawlor of RTE chaired the discussion between the leading academic researcher and commercial entrepreneur in this exciting new sector. Denis Noble, Emeritus professor of physiology at Oxford and the first researcher to map and build a virtual human heart joined Linda Avey, who as the founder of both Curious Labs inc and 23andMe is a leader in commercially led research.